Medtronic To Acquire Salient Surgical Technologies, Inc. (press release)
The numbers...
$535M total price
Price = 5.3 X annual sales of $100M
Medtronic previously owned 8.5% of Salient
MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire Salient Surgical Technologies, Inc., the leader in the advanced energy category for haemostatic sealing of soft tissue and bone in a variety of surgical procedures including orthopaedic surgery, spine, open abdominal and thoracic procedures. Salient’s AQUAMANTYS® system with patented TRANSCOLLATION® technology will broaden Medtronic Surgical Technologies’ portfolio of innovative surgical products to meet customer and patient needs worldwide.
“Integrating the Salient Surgical Technologies organization will bring new applications to Medtronic Surgical Technologies’ current surgical therapy areas and expand the company’s opportunities in adjacent offerings, helping Medtronic serve new customers and better meet the needs of existing ones”
The total value of the transaction is $525 million. Medtronic had previously invested in Salient and currently holds an owne...
